Assessing frontal lobe function in patients with amyotrophic lateral sclerosis by frontal assessment battery

Clinical Neurology

Volumn 50, Issue 6, 2010, Pages 379-384

  Terada, Tatsuhiro ^a,b   Obi, Tomokazu ^a   Miyajima, Hiroaki ^b   Mizoguchi, Kouichi ^a  

^a SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); Frontal Assessment Battery (FAB); Frontal lobe function

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD GAS ANALYSIS; BRAIN DYSFUNCTION; BRAIN FUNCTION; CLINICAL ARTICLE; DEPRESSION; DISEASE DURATION; DYSARTHRIA; FEMALE; FRONTAL LOBE; HUMAN; MALE; MENTAL PATIENT; MINI MENTAL STATE EXAMINATION; MUSCLE WEAKNESS; NEUROPSYCHOLOGICAL TEST; RATING SCALE; SELF CONCEPT; SPEECH; SPIROMETRY;

EID: 77954401804     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.50.379     Document Type: Article

References (28)

1. Kim SM, Lee KM, Hong YH, et al. Relation between cognitive dysfunction and reduced vital capacity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007;78:1387-1389.
2. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-133.
3. Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602-611.
4. Lomen-Hoerth C, Murphy J, Langmore S, et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003;60:1094-1097.
5. Dubois B, Slachevsky A, Litvan I, et al. The FAB: A frontal assessment battery at bedside. Neurology 2000;55:1621-1626.
6. Beghi E, Balzarini C, Bogliun G, et al. Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis. Neuroepidemiology 2002;21:265-270.
7. Mitsuyama Y. Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases. J Neurol Neurosurg Psychiatry 1984;47:953-959. (Pubitemid 14074511)
8. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-935.
9. Lipton AM, Ohman KA, Womack KB, et al. Subscores of the FAB differentiate frontotemporal lobar degeneration from AD. Neurology 2005;5:726-731. (Pubitemid 41285852)
10. Paviour DC, Winterburn D, Simmonds S, et al. Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychologocal testing. Neurocase 2005;11:274-282. (Pubitemid 41179598)
11. Grossman AB, Woolley-Levine S, Bradley WG, et al. Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007;8:56-61. (Pubitemid 46322941)
12. Abrahams S, Goldstein LH, Al-Chalabi A, et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1997;62:464-472. (Pubitemid 27237054)
13. Rippon GA, Scarmeas N, Gordon PH, et al. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol 2006;63:345-352.
14. Neary D, Snowden JS, Mann DM. Cognitive change in motor neuron disease/amyotrophic lateral sclerosis (MND/ALS). J Neurol Sci 2000;180:15-20.
15. Murphy J, Henry R, Lomen-Hoerth C. Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007;64:330-334. (Pubitemid 46425686)
16. Abe K, Fujimura H, Toyooka K, et al. Single-photon emission computed tomographic investigation of patients with motor neuron disease. Neurology 1993;43:1569-1573.
17. Yoshida M. Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum. Neuropathology 2004;24:87-102.
18. Nishihira Y, Tan CF, Hoshi Y, et al. Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology. Acta Neuropathol 2009;117:45-53.
19. Geser F, Martinez-Lage M, Robinson J, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 2009;66:180-189.